Carregant...
Duloxetine pharmacokinetics are similar in Japanese and Caucasian subjects
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: The pharmacokinetics of duloxetine have been assessed in a number of clinical studies. Duloxetine is eliminated through oxidative metabolism via CYP1A2 and, to a lesser degree, CYP2D6. There is strong evidence that the prevalence of CYP2D6 phenotypes and the...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Blackwell Science Inc
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2000724/ https://ncbi.nlm.nih.gov/pubmed/17380590 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2006.02770.x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|